Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
I. Tanboga, B. Kargul, S. Ergeneli, M.Y. Aydin, M. Atasu.
Clinical features of incontinentia pigmenti with emphasis on dermatology findings.
J Clin Pediatr Dentistry, 25 (2000), pp. 161-165
[2.]
A.L. Berlin, A.S. Paller, L.S. Chan.
Incontinentia pigmenti: A review and update on molecular basis of pathophysiology.
J Am Acad Dermatology, 47 (2002), pp. 169-187
[3.]
S. Hadj-rabia, D. Froidevaux, N. Bodak, D. Hamel-Teillac, A. Smahi, Y. Touil, et al.
Clinical study of 40 cases of incontinentia pigmenti.
Arch Dermatology, 139 (2003), pp. 1163-1170
[5.]
A. Smahi, G. Courtois, P. Vabres, S. Yamaoka, S. Heuertz, A. Munich, et al.
for the International Incontinentia Pigmenti (IP) Consortium. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti.
Nature, 405 (2000), pp. 466-472
[6.]
J. Pearlman, R.D. Griego, M.L. Levy, J. Friedman.
An usual presentation of incontinentia pigmenti in a 4-month-old girl.
Pediatric Dermatology, 13 (1996), pp. 47-50
[7.]
G.L. Darmstadt.
Hyperpigmented lesions.
Nelson Textbook of Pediatrics, 16.a ed, pp. 1983-1985
[8.]
J.L. Roberts.
Clarification of a Diagnosis of Incontinentia Pigmenti.
Am J Med Genetics, 85 (1999), pp. 426
Copyright © 2004. Asociación Española de Pediatría
